|
OMIM |
Link |
Information gain |
01 |
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.00123814
|
|
|
NR3C2
|
[NCBI]
|
0.00116585
|
|
|
PHA1
|
[NCBI]
|
0.000906535
|
|
|
pseudohypoaldosteronism, type i, autosomal dominant
|
[NCBI]
|
0.000679094
|
|
|
PHA2
|
[NCBI]
|
0.000619433
|
|
|
WNK4
|
[NCBI]
|
0.000423458
|
|
|
SCNN1A
|
[NCBI]
|
0.000190863
|
|
|
WNK1
|
[NCBI]
|
0.000190863
|
|
|
SCNN1B
|
[NCBI]
|
0.000174845
|
|
|
SCNN1G
|
[NCBI]
|
0.000125778
|
|
|
liddle syndrome
|
[NCBI]
|
7.85178e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
7.75502e-05
|
|
|
c syndrome
|
[NCBI]
|
7.47703e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
7.36928e-05
|
|
|
dent disease 1
|
[NCBI]
|
7.36928e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
6.22591e-05
|
|
|
GRA
|
[NCBI]
|
5.12757e-05
|
|
|
hypertension, essential
|
[NCBI]
|
5.07731e-05
|
|
|
AHO
|
[NCBI]
|
4.38862e-05
|
|
|
AQP1
|
[NCBI]
|
3.84781e-05
|
|
|
NPPA
|
[NCBI]
|
8.19876e-06
|
|
|
CF
|
[NCBI]
|
2.53484e-06
|
|